Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
D
Details...
Enter Symbol
Dr. Reddy's Laboratories Ltd (NYSE: RDY)
Sector: Medical
Current Price :
$30.26
52 Week Low
$29.07
52 Week High
$37.82
Company
Overview
Research Notes
Company Profile
Competitors
Community
Wiki
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Related News
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
169M
Market Cap:
$5.49B
Avg Volume:
211791
P/E Ratio:
19.060
PEG Ratio:
0.660
Split:
On 9/7/2006 rdy split by factor of 2.000
Trade now with
1m
3m
6m
1y
2y
Opinion and Analysis
My Three New Indian Stock Buys
Jan 31, 2012 03:11 PM |
HDB
,
INFY
,
RDY
The 2 Best Stocks For This $33 Billion Trend
Sep 26, 2011 02:22 PM |
ABC
,
AZN
,
BANR
,
BBI
,
BMY
,
C
Seven Bear Stocks In Healthcare - Q3 Update
Sep 15, 2011 11:16 AM |
AMLN
,
ENDP
,
HSP
,
NVO
,
RDY
,
REGN
Dr. Reddy’S Laboratories Ltd. (NYSE: RDY) Reports $904M In Q4
May 13, 2011 12:19 PM |
RDY
Big Pharma Faces Major Roadblocks In India
Apr 20, 2011 11:46 AM |
ABT
,
BBBB
,
GSK
,
PFE
,
RDY
More Articles on RDY..
Market News
FIIs sell bank, telecom and steel; buy cement, construction stocks
Oct 21, 2011 05:40 AM |
RDY
Aurobindo Pharma ties up with Russian firm
Sep 08, 2011 05:43 AM |
RDY
India attempting to deepen trade ties with Latin America
Aug 29, 2011 05:43 AM |
RDY
,
TTM
Sun Pharma net drops 11% to '501 crore
Jul 29, 2011 06:48 PM |
RDY
Aurobindo Pharma net up 13%, plans spin-off
May 10, 2011 05:52 AM |
ABT
,
RDY
More News on RDY..
Press Releases
Genpact Signs Business Process Management Engagement with Dr. Reddy's Laboratories
May 22, 2012 02:30 AM |
G
,
RDY
Dr. Reddy's Announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules
May 21, 2012 12:21 AM |
RDY
Dr. Reddy's Announces the Launch of Clopidogrel Tablets, USP
May 18, 2012 01:23 AM |
RDY
More Press Releases on RDY..
SEC Filings
More SEC Filings on RDY..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
RDY
Compare to S&P
YTD
10.09 %
1.50 %
4 Weeks
-4.96 %
-4.08 %
12 Weeks
-1.13 %
-2.41 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
50.00 %
EPS Growth in Last Year:
50.00 %
Sales Growth in Last Quarter:
12.99 %
Sales Growth in Last Quarter:
23.11 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##